4//SEC Filing
Protea Biosciences Group, Inc. 4
Accession 0001144204-14-054699
CIK 0001335103operating
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 11:38 AM ET
Size
8.3 KB
Accession
0001144204-14-054699
Insider Transaction Report
Form 4
ANTOLINE STEVE
Director10% Owner
Transactions
- Purchase
Warrant
2014-09-04$140000.00/sh+175,000$24,500,000,000→ 7,500,847 totalExercise: $0.80From: 2014-09-04Exp: 2019-09-04→ Common Stock (175,000 underlying) - Purchase
Warrant
2014-09-04$140000.00/sh+175,000$24,500,000,000→ 7,500,847 total(indirect: By Summit Resources, Inc.)Exercise: $0.80From: 2014-09-04Exp: 2019-09-04→ Common Stock (175,000 underlying)
Footnotes (2)
- [F1]Represents the shares of Common Stock of the Issuer owned of record by Summit Resources, Inc. Steve Antoline has voting and dispositive control over any securities owned of record by Summit Resources, Inc. and may be deemed to beneficially own the shares of common stock held of record by Summit Resources, Inc.
- [F2]On September 4, 2014, the Company issued a promissory note for $175,000 to the Reporting Person and, entered into a Note and Warrant Purchase Agreement and issued a related five-year warrant to purchase 175,000 shares of the Company's common stock at $0.80 per share.
Documents
Issuer
Protea Biosciences Group, Inc.
CIK 0001335103
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001335103
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 11:38 AM ET
- Size
- 8.3 KB